Shihao Sun

Shihao Sun

Auto-generated profile, based on publicly available information

Shihao Sun

Department of Nursing, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in European Journal of Cancer Care
Verified
Journal Article
Open access
PDF file
FPFulin Pu
Fulin Pu
LZLijuan Zhang
Lijuan Zhang
YZYiheng Zhang
Yiheng Zhang
SSShihao Sun
Shihao Sun
NLNa Li
Na Li
MZMeifen Zhang
Meifen Zhang
Background . Adherence to complete decongestion therapy (CDT) is of utmost importance for patients with breast cancer‐related lymphedema (BCRL). However, past studies have demonstrated that adherence to CDT in BCRL patients is less than satisfactory. Our study aimed to describe the level of adherence to CDT among BCRL patients and utilize the Health Belief Model to analyse the key factors that influence adherence. Methods . We employed a convenient sampling method to select 158 patients with BCRL who were in the maintenance stage of CDT in a grade A tertiary tumour hospital in Guangzhou. A questionnaire survey was used to investigate patients’ adherence to CDT, as well as their sociodemographic characteristics, medical history characteristics, disease knowledge, and health beliefs. Results . The CDT adherence score of BCRL patients was 96.46 ± 18.46 points, with an average score of 2.61 ± 0.50 points per item. The adherence rate was 65.18 ± 12.47%, indicating a moderate level of adherence. Factors that significantly influenced CDT adherence in BCRL patients included age under 45 years, having 0 or 1 child, experiencing 9 lymphedema symptoms, and having low levels of disease knowledge and health beliefs ( p < 0.05). Conclusions . The level of adherence to CDT in BCRL patients is moderate and requires improvement. To enhance adherence to CDT, medical professionals should focus on patients who are younger, have fewer children, exhibit fewer symptoms of lymphedema, possess limited disease knowledge, and have weak health beliefs.

17 April 2026 in Journal of Medical Internet Research
Verified
Journal Article
Open access
YZYiheng Zhang
Yiheng Zhang
HHHaiyan He
Haiyan He
YZYe Zhang
Ye Zhang
YZYouxian Zhong
Youxian Zhong
CLChunhong Luo
Chunhong Luo
MZMeifen Zhang
Meifen Zhang
Background: Young- to middle-aged patients with breast cancer face significant psychosocial challenges. Existing interventions often lack comprehensiveness, timely initiation, and tailoring specific to this population’s unique needs. Objective: This study aimed to evaluate the impact of a peer-led, nurse-involved, blended online and offline peer support intervention program (PNO2PSP) on psychosocial adjustment in young- to middle-aged patients with breast cancer. Methods: The effectiveness of PNO2PSP was evaluated through a single-center cluster randomized controlled trial involving 70 newly diagnosed young- to middle-aged patients with breast cancer (35 in each group). The intervention group received an 8-week PNO2PSP in addition to routine care. Psychosocial adjustment, self-efficacy, social support, and coping modes were assessed presurgery and at 4, 8, and 12 weeks post surgery. Generalized estimating equations were used for intention-to-treat analyses. In-depth interviews with 9 participants explored their experiences. Results: Compared to the control group, the intervention group demonstrated significantly lower psychosocial adjustment scores at 8 weeks (T2; Wald χ² 1 =14.96; P <.001) and 12 weeks (T3; Wald χ² 1 =7.49; P =.006); social support was higher at 8 weeks (T2; Wald χ² 1 =7.65; P =.006). Confrontation coping scores were higher at T2 (Wald χ² 1 =5.46; P =.02), T3 (Wald χ² 1 =10.04; P =.002), while avoidance coping scores were lower at T1 (Wald χ² 1 =8.24; P =.004), T2 (Wald χ² 1 =7.45; P =.006), and T3 (Wald χ² 1 =5.70; P =.02). Qualitative findings supported these quantitative results, highlighting the program’s role in facilitating psychosocial adjustment, providing vital support, boosting treatment confidence, and fostering positive coping. Conclusions: The PNO2PSP effectively improved psychosocial adjustment, social support, and positive coping in young- to middle-aged patients with breast cancer. Its scientifically validated, feasible, and patient-centered design supports its recommendation for wider clinical implementation, with continued training for peer supporters and sustained delivery of peer support.